Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Compact case
Case
-
Reference no. IMD-7-1664
Published by: International Institute for Management Development (IMD)
Originally published in: 2015
Version: 30.10.2015
Length: 4 pages
Data source: Published sources

Abstract

In 2006, after developing his firm for 40 years, Bangpeng, the founder of Zhejiang Hisoar Pharmaceutical turned it into a public company. He remained at its head until 2010 when, for health reasons, he stepped down and sold his remaining share at 50 percent of the market price to his still inexperienced son, Yuhong, making him the controlling owner. During the next few years, the company suffered from unfavorable market conditions and new regulatory hurdles eventually forcing Yuhong to resign as chairman and sell his share.
Locations:
Size:
1,700+ employees
Other setting(s):
2006-2014

About

Abstract

In 2006, after developing his firm for 40 years, Bangpeng, the founder of Zhejiang Hisoar Pharmaceutical turned it into a public company. He remained at its head until 2010 when, for health reasons, he stepped down and sold his remaining share at 50 percent of the market price to his still inexperienced son, Yuhong, making him the controlling owner. During the next few years, the company suffered from unfavorable market conditions and new regulatory hurdles eventually forcing Yuhong to resign as chairman and sell his share.

Settings

Locations:
Size:
1,700+ employees
Other setting(s):
2006-2014

Related